China's Sinovac Biotech Ltd launched on Tuesday (August 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.

The candidate, known as CoronaVac and previously PiCoVacc, is among few potential vaccines that have entered late-stage trials for a large-scale study to gather proof of efficacy for regulatory approval.

CoronaVac is already undergoing a late-stage trial in Brazil slated for as many as 9,000 people.

Its Indonesia trial comes as Southeast Asia's most populous country grapples with spiking infection numbers, with over 127,000 cases recorded as of Tuesday. The trial has so far recruited 1,215 people and will last six months.

A ceremony for the launch on Tuesday in Bandung, West Java, was attended by Indonesia's President Joko Widodo.

"The threat of COVID-19 will not subside until a vaccine is given to all the people," Widodo said.

Sinovac expects to also test the vaccine candidate in Bangladesh.

Separately, Sinovac late on Monday (August 10) released details from a mid-stage, or Phase 2, study in which it said the vaccine candidate appeared to be safe and induced detectable antibody-based immune responses in subjects.

In the Phase 2 clinical trial involving 600 participants in China, the candidate did not cause any serious side effect and the rate of fever was relatively low compared with other COVID-19 candidates, the paper showed ahead of peer review.

Sinovac has to test its vaccine abroad because China is no longer a satisfactory site for late-stage trials due to the low number of new infection cases.

Source: Reuters

Related Topics


Existential danger from COVID-19 pandemic

The danger from the COVID-19 pandemic is still latent, threatening people’s health and lives in the context that the immunity provided from the COVID-19 vaccine has decreased. Many other dangerous diseases are also likely to break out when the global vaccination rate slows down, due to inequality in access to health services, vaccine hesitancy, and consequences of economic recession.

Vietnam among ASEAN countries recording EV sales surge

The Association of Southeast Asian Nations (ASEAN) is witnessing a rise in the sales of electric vehicles (EVs) in Vietnam, Malaysia and Indonesia, according to Maybank Investment Bank Research (Maybank IB Research).

International friends bid farewell to Party General Secretary Nguyen Phu Trong

The respect paying ceremony for Party General Secretary Nguyen Phu Trong continued on the morning of July 26 at the National Funeral Hall in Hanoi, with high-level delegations from foreign countries and international organisations paying their last respects and expressing deep condolences.

Global outpouring of grief for Vietnamese Party chief

A wave of condolences have poured in from world leaders, international organisations, rulling parties, Communist parties and partner parties following the death of Vietnamese Party General Secretary Nguyen Phu Trong.

Party General Secretary Nguyen Phu Trong, a revered leader in Vietnam and world: Australian Senate President

President of the Australian Senate Sue Lines has expressed her deepest sympathy over the passing of General Secretary of the Communist Party of Vietnam Central Committee Nguyen Phu Trong and affirmed that he is a revered leader both in Vietnam and across the world.

Vietnam hopes UN, ASEAN coordinate closely, effectively over Myanmar issue: Ambassador

Ambassador Dang Hoang Giang, Vietnam’s Permanent Representative to the United Nations (UN), on June 5 had a meeting with UN Secretary-General’s Special Envoy on Myanmar Julie Bishop during her working visit to New York.